Oruka Therapeutics (ORKA) EBT Growth (1y) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -80.95% |
| Mar 31, 2024 | -49.26% |
| Dec 31, 2023 | 7.24% |
| Sep 30, 2023 | 38.96% |
| Jun 30, 2023 | 52.97% |
| Mar 31, 2023 | 58.86% |
| Dec 31, 2022 | 79.32% |
| Sep 30, 2022 | 50.49% |
| Jun 30, 2022 | 34.90% |
| Mar 31, 2022 | 20.20% |
| Dec 31, 2021 | -10.75% |
| Sep 30, 2021 | -136.66% |
| Jun 30, 2021 | -268.73% |
| Mar 31, 2021 | -210.61% |
| Dec 31, 2020 | -312.64% |
| Sep 30, 2020 | -66.19% |
| Jun 30, 2020 | 10.39% |
| Mar 31, 2020 | 24.40% |
| Dec 31, 2019 | 16.59% |
| Sep 30, 2019 | 26.23% |
| Jun 30, 2019 | 30.86% |
| Mar 31, 2019 | 36.16% |
| Dec 31, 2018 | 65.03% |
| Sep 30, 2018 | 63.37% |
| Jun 30, 2018 | 61.68% |
| Mar 31, 2018 | 36.95% |
| Dec 31, 2017 | -0.33% |
| Sep 30, 2017 | 4.85% |
| Jun 30, 2017 | -41.81% |
| Mar 31, 2017 | -18.95% |
| Dec 31, 2016 | -33.96% |
| Sep 30, 2016 | -65.57% |
| Jun 30, 2016 | -43.21% |
| Mar 31, 2016 | -32.91% |
| Dec 31, 2015 | -21.33% |
| Sep 30, 2015 | -23.20% |
| Jun 30, 2015 | -13.06% |
| Mar 31, 2015 | -14.86% |
| Dec 31, 2014 | 11.37% |
| Sep 30, 2014 | -32.56% |
| Jun 30, 2014 | -100.58% |
| Mar 31, 2014 | -123.06% |
| Dec 31, 2013 | -250.71% |
| Sep 30, 2013 | -85.87% |
| Jun 30, 2013 | -4.62% |
| Mar 31, 2013 | 23.88% |
| Dec 31, 2012 | 48.47% |
| Sep 30, 2012 | 49.12% |
| Jun 30, 2012 | -489.80% |
| Mar 31, 2012 | 36.22% |
| Dec 31, 2011 | -2.19% |
| Sep 30, 2011 | 13.49% |
| Jun 30, 2011 | 112.95% |